TP53 and breast carcinoma: Although it has been demonstrated that SETD3 is required for p53 target gene recruitment and the induction of apoptosis in response to DNA damage in cancer colon cells23, in our study we observed that downregulation of SETD3 is associated with reduced viability of aggressive breast cancer cells.